In the New England Journal of Medicine, scientists report that a new experimental drug called ibrutinib significantly prolongs the life of chronic lymphocytic leukemia (CLL) with fewer side effects than chemotherapy. To learn more, click here…..
Better Living Through Innovation
In the New England Journal of Medicine, scientists report that a new experimental drug called ibrutinib significantly prolongs the life of chronic lymphocytic leukemia (CLL) with fewer side effects than chemotherapy. To learn more, click here…..
Leave a Reply